Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
Clinical trial NCT06240754 · RECRUITING
Trial details
- NCT number
- NCT06240754
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2028-05-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.